Key Record Dates
| ClinicalTrials.gov Identifier: | NCT05243550 |
|---|---|
| Brief Title: | A Phase 3 Single-Arm Study of UGN-102 for Treatment of Low Grade Intermediate Risk Non-Muscle-Invasive Bladder Cancer (ENVISION) |
| First Submitted : | February 7, 2022 |
| First Submitted that Met QC Criteria : | February 7, 2022 |
| First Posted : | February 17, 2022 |
| Last Update Submitted that Met QC Criteria : | December 16, 2022 |
| Last Update Posted : | December 20, 2022 |